Dr. Søren Mouritsen, co-founder of Engimmune, steps down as Chief Executive Officer in planned transition BASEL, Switzerland, April 19, 2023 /PRNewswire/ — Engimmune Therapeutics AG (“Engimmune”), a Swiss biotech company developing novel T-cell receptor (TCR)-based therapeutics, today…